In myeloma cells, ERK5 acts downstream of interleukin (IL) 6, a cytokine that plays an important function in MM cell proliferation and survival, and IL-6-dependent activation of ERK5 occurs through a RAS- and SRC-dependent pathway. Here, MAPK7 is linked to plasma cell myeloma.